| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AAPL | Technology | Barclays | Reiterates | Underweight | $245 | $4.5T | $333.43 | -8.6% | -7.4% | -1.8% | +2.0% | +0.5% | +0.5% |
| AAPL | Technology | Goldman | Reiterates | Buy | $360 | $4.5T | $333.43 | -8.6% | -7.4% | -1.8% | +2.0% | +0.5% | +0.5% |
| AAPL | Technology | JP Morgan | Reiterates | Overweight | $340 | $4.5T | $333.43 | -8.6% | -7.4% | -1.8% | +2.0% | +0.5% | +0.5% |
| AAPL | Technology | Morgan Stanley | Reiterates | Overweight | $360 | $4.5T | $333.43 | -8.6% | -7.4% | -1.8% | +2.0% | +0.5% | +0.5% |
| AAPL | Technology | Wells Fargo | Reiterates | Overweight | $350 | $4.5T | $333.43 | -8.6% | -7.4% | -1.8% | +2.0% | +0.5% | +0.5% |
| AAPL | Technology | TD Cowen | Reiterates | Buy | $400 | $4.5T | $333.43 | -8.6% | -7.4% | -1.8% | +2.0% | +0.5% | +0.5% |
| AMZN | Consumer Cyclical | TD Cowen | Reiterates | Buy | $350 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Pivotal Research Group | Reiterates | Buy | $333 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Barclays | Reiterates | Overweight | $365 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Citigroup | Reiterates | Buy | $350 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | JP Morgan | Reiterates | Overweight | $365 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Robert W. Baird | Reiterates | Outperform | $310 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | UBS | Reiterates | Buy | $318 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Wells Fargo | Reiterates | Overweight | $328 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Cantor Fitzgerald | Reiterates | Overweight | $320 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | BofA Securities | Reiterates | Buy | $320 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | KeyBanc Capital Markets | Reiterates | Overweight | $350 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Goldman | Reiterates | Buy | $375 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Piper Sandler | Reiterates | Overweight | $320 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |
| AMZN | Consumer Cyclical | Mizuho | Reiterates | Outperform | $330 | $2.9T | $235.50 | +12.5% | +15.3% | +4.6% | -2.3% | -1.7% | -0.1% |